Nadine Frerker1, Tommy A Karlsen1, Magnus Borstad Lilledahl2, Sverre-Henning Brorson3, John E Tibballs4, Jan E Brinchmann1,5. 1. Department of Immunology, Oslo University Hospital, Oslo, Norway. 2. Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway. 3. Department of Pathology, Oslo University Hospital, Oslo, Norway. 4. Nordic Institute of Dental Materials, Oslo, Norway. 5. Department of Molecular Medicine, University of Oslo, Oslo, Norway.
Abstract
OBJECTIVE: Despite new strategies in tissue engineering, cartilage repair remains a major challenge. Our aim is to treat patients with focal lesions of articular cartilage with autologous hyaline cartilage implants using a scaffold-free approach. In this article, we describe experiments to optimize production of scaffold-free cartilage discs. DESIGN: Articular chondrocytes were expanded in vitro, seeded in transwell inserts and redifferentiated using established chondrogenic components. Experimental variables included testing 2 different expansion media, adding bone morphogenetic protein 2 (BMP2), insulin-like growth factor 1 (IGF1), growth/differentiation factor 5 (GDF5), or fibroblast growth factor 18 (FGF18) to the differentiation medium and allowing the disc to float freely in large wells. Cartilage discs were analyzed by weight and thickness, real-time RT-qPCR (reverse transcriptase qualitative polymerase chain reaction), fluorescence immunostaining, transmission electron microscopy, second harmonic generation imaging, and measurement of Young's modulus. RESULTS: Addition of BMP2 to the chondrogenic differentiation medium (CDM) was essential for stable disc formation, while IGF1, GDF5, and FGF18 were redundant. Allowing discs to float freely in CDM on a moving platform increased disc thickness compared with discs kept continuously in transwell inserts. Discs cultured for 6 weeks reached a thickness of almost 2 mm and Young's modulus of >200 kPa. There was abundant type II collagen. Collagen fibrils were 25 nm thick, with a tendency to be organized perpendicular to the disc surface. CONCLUSION: Scaffold-free engineering using BMP2 and providing free movement in CDM produced firm, elastic cartilage discs with abundant type II collagen. This approach may potentially be used in clinical trials.
OBJECTIVE: Despite new strategies in tissue engineering, cartilage repair remains a major challenge. Our aim is to treat patients with focal lesions of articular cartilage with autologous hyaline cartilage implants using a scaffold-free approach. In this article, we describe experiments to optimize production of scaffold-free cartilage discs. DESIGN: Articular chondrocytes were expanded in vitro, seeded in transwell inserts and redifferentiated using established chondrogenic components. Experimental variables included testing 2 different expansion media, adding bone morphogenetic protein 2 (BMP2), insulin-like growth factor 1 (IGF1), growth/differentiation factor 5 (GDF5), or fibroblast growth factor 18 (FGF18) to the differentiation medium and allowing the disc to float freely in large wells. Cartilage discs were analyzed by weight and thickness, real-time RT-qPCR (reverse transcriptase qualitative polymerase chain reaction), fluorescence immunostaining, transmission electron microscopy, second harmonic generation imaging, and measurement of Young's modulus. RESULTS: Addition of BMP2 to the chondrogenic differentiation medium (CDM) was essential for stable disc formation, while IGF1, GDF5, and FGF18 were redundant. Allowing discs to float freely in CDM on a moving platform increased disc thickness compared with discs kept continuously in transwell inserts. Discs cultured for 6 weeks reached a thickness of almost 2 mm and Young's modulus of >200 kPa. There was abundant type II collagen. Collagen fibrils were 25 nm thick, with a tendency to be organized perpendicular to the disc surface. CONCLUSION: Scaffold-free engineering using BMP2 and providing free movement in CDM produced firm, elastic cartilage discs with abundant type II collagen. This approach may potentially be used in clinical trials.
Entities:
Keywords:
cartilage repair; chondrogenic redifferentiation; human articular chondrocytes; human cartilage implants; tissue engineering
Patients with focal chondral defects can be treated with surgical techniques such as
autologous chondrocyte implantation or microfracture. These methods improve
functionality and provide pain relief, but result in imperfect tissue
repair.[1,2]
Several strategies to redifferentiate chondrocytes in 3-dimensional structures such
as pellet cultures or biomaterial matrices have been studied. Pellet cultures serve
as a study model but require a large number of cells to generate cartilage
constructs of sufficient size.
Biomaterials, on the other hand, are used for the fabrication of scaffolds to
be applied in next-generation autologous chondrocyte implantation and tissue
engineering. The matrix material is either of biological or synthetic polymeric
origin and has to fulfill certain criteria such as being biocompatible and
biodegradable while having adequate mechanical properties and scaffold architecture.
Drawbacks can be lack of attachment sites for cells, unwanted mechanical properties,
insufficient biocompatibility and integrity, or unpredictable biodegradation of the
material.[4-6]An alternative to the implantation of cells within a biomaterial scaffold is the
in vitro culture of cells spun onto a transwell insert. Here
the cells produce their own extracellular matrix (ECM) in a scaffold-free
environment. The end product is a disc-shaped tissue containing chondrocytes and
their ECM.[7,8] However, in
order to produce ECM molecules that are as similar as possible in type and amount to
those found in native articular cartilage, the cells need to be stimulated by the
right composition of growth and differentiation factors. Here, we present an
approach to optimize the formation of cartilage discs that could potentially be
transplanted into cartilage lesions. We have investigated a number of factors that
might improve both the process by which the chondrocytes are expanded in cell
culture and also the phase during which the chondrocytes are redifferentiated in
transwell inserts to produce discs of cartilaginous tissue. Using molecular assays,
established and novel imaging techniques, and a testing scheme for biophysical
properties we have improved the production of transplantable cartilage discs.
Methods
Isolation and Culture of Chondrocytes
All donors provided written, informed consent, and the study was approved by the
Regional Committee for Ethics in Medical Research. Osteoarthritis (OA) articular
cartilage was obtained from discarded tissue from 6 patients (donors 1-6) with
primary OA undergoing knee replacement surgery. As part of the ethical approval
of this study, donor demographics were not made available to the scientific
team. Cartilage pieces were taken from a part of the surface of the femoral
condyle that, by inspection, seemed not to be diseased. Further biopsies were
provided from 1 patient undergoing cruciate ligament surgery (donor 7) and 1
patient undergoing meniscus surgery (donor 8). The cartilage tissue was cut and
digested as described previously,
then resuspended in DMEM/F12 GlutaMAX medium (Gibco) supplemented with
10% human platelet lysate plasma (hPLP), modified after Schallmoser and Strunk,
with 2 IU/mL heparin (Wockhardt), 10 ng/mL fibroblast growth factor-basic
(bFGF; Gibco), 100 units/mL penicillin, and 100 µg/mL streptomycin (P/S;
Sigma-Aldrich), and 2.5 µg/mL amphotericin B (Sigma-Aldrich). In some
experiments the use of 10% autologous serum
instead of hPLP was tested. The hPLP and autologous serum were sterile
filtered prior to use. The cells were expanded in tissue culture plastic flasks,
and the culture medium was changed every 3 to 4 days. For passaging, cells at
70% to 90% confluency were trypsinized and passaged at a ratio of 1:3 for
further cultivation. Amphotericin B was discontinued after 1 week. Chondrocytes
were expanded for 14 days prior submission to chondrogenic redifferentiation.
Although some differences were observed between the donors for the chondrocytes’
ability to proliferate in vitro, we never failed to have
sufficient number of cells for experiments at this time point. Consistent with
observations made in our GMP regulated cell production facility (data not
shown), addition of bFGF to the cell expansion medium seemed to reduce
differences in proliferation capability between donors.
Chondrogenic Differentiation Medium
The basic chondrogenic differentiation medium (CDM) was DMEM/F12 GlutaMAX
supplemented with 10 ng/mL transforming growth factor β1 (TGFβ1; R&D
systems), 1% insulin-transferrin-sodium selenite media supplement
(Sigma-Aldrich), 0.1 µM dexamethasone (DexaGalen, GALENpharma), 0.1 mM ascorbic
acid 2-phosphate (Sigma-Aldrich), 1.25 mg/mL human serum albumin (Octapharma),
4.5 g/L glucose (B. Braun), 40 µg/mL proline (Sigma-Aldrich), 1 mM sodium
pyruvate (Gibco), and P/S. Growth factors tested in CDM were 500 ng/mL bone
morphogenetic protein 2 (BMP2; InductOs), 100 ng/mL insulin-like growth factor 1
(IGF1; Sigma-Aldrich), 100 ng/mL growth/differentiation factor 5 (GDF5;
PeproTech), and 100 ng/mL fibroblast growth factor 18 (FGF18; PeproTech).
Cartilage Disc Preparation
A total of 0.5 × 106 cells were resuspended in 150 µL of CDM, with or
without additional growth factors, and seeded in 6.5-mm polycarbonate transwell
inserts in 24-well plates (Corning). The plates were centrifuged for 5 minutes
at 200g and 700 µL of the CDM to be tested was carefully added
to the bottom wells. Medium was changed every second day, including the insert
top. Cartilage discs were either grown in transwell inserts (confined cultures),
or discs were carefully stripped off the transwell membrane after 10 days and
allowed to float freely in medium in 6-well plates, which were placed on a
shaker that rotated at 50 to 65 rpm (unconfined cultures). Cartilage discs were
harvested after 3 or 6 weeks of chondrogenic redifferentiation. The discs were
washed with PBS and further treated as described below.
Isolation of Total RNA, cDNA Synthesis, and Real-Time RT-qPCR
Cartilage discs were snap-frozen in liquid nitrogen and stored at −80 °C until
processing. Frozen discs were crushed in liquid nitrogen with a pestle and total
RNA was isolated following the protocol in the miRNeasy mini kit (Qiagen). cDNA
synthesis and real-time RT-qPCR (reverse transcriptase qualitative polymerase
chain reaction) were performed according to the manufacturer’s instructions of
the High Capacity cDNA Reverse Transcription Kit and TaqMan 2x Universal PCR
Master Mix (both Applied Biosystems). cDNA samples were probed for cartilage
relevant genes using primers from Applied Biosystems. All samples were run in
technical triplicates. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) served as endogenous control. Results are shown as
expression relative to GAPDH using mean values from technical
triplicates with a 95% confidence interval.
Immunofluorescence Analysis
Cartilage samples were embedded in Frozen Section Medium (Richard-Allan
Scientific Neg50, Thermo Scientific) and frozen in dry ice-cooled isopentane.
Frozen tissue blocks were stored at −80 °C. The samples were cut in 9- to 10-µm
thick sections on a CryoStar NX70 Cryostat (Thermo Scientific), mounted on
SuperFrost Plus Adhesion slides, stored at −80 °C and fixed for 60 seconds in
cold 95% ethanol directly before starting immunostaining. Sections were
immunostained for the presence of type II collagen (COL2; clone II-4C11; MP
Biomedicals; at 0.833 µg/mL), aggrecan (ACAN; clone 4F4; Santa Cruz; at 0.1
µg/mL), type I collagen (COL1; clone EPR7785; Abcam; at 0.8 µg/mL), type X
collagen (COL10; clone X53 diluted 1:200; generous gift from Prof. Klaus von der
Mark). Antibodies were diluted in 1.25% BSA in PBS, and slides were incubated at
4 °C overnight. Negative controls were made by omitting the primary antibody.
The secondary antibodies, goat anti-mouse IgG conjugated to Alexa 594 and goat
anti-rabbit IgG conjugated to Alexa 488 (both Life Technologies), were diluted
1:400. The stained sections were mounted with ProLong Gold antifade reagent
(Invitrogen), containing DAPI for nuclear staining. Imaging was done using an
upright Nikon Eclipse E600 microscope equipped with an Olympus ColorView III
camera. Thickness of cartilage discs was measured using histological
sections.
Phalloidin Staining
Chondrocytes at day 17 of culture were seeded on coverslips in
hPLP/bFGF-supplemented culture medium. After 24 hours the cells were carefully
washed and medium was exchanged with CDM with or without BMP2. After further 24
hours of differentiation cells were fixed with 4% paraformaldehyde for 15
minutes at room temperature, permeabilized in 0.1% Triton X-100 for 3 to 5
minutes and labeled with phalloidin (Phalloidin-iFluor 488 Reagent, ab176753,
Abcam) according to the manufacturer’s protocol. Coverslips were mounted on
microscope slides using Fluoroshield with DAPI (Sigma). Fluorescent images were
taken using an upright Nikon Eclipse E600 microscope equipped with an Olympus
ColorView III camera. Light microscopy images were taken before staining of
samples using a Zeiss Axio Vert.A1 inverted microscope equipped with a Zeiss
AxioCam MRm camera.
Mechanical Testing
The cartilage discs were subjected to displacement-controlled mechanical testing
in an electrodynamic instrument (Bose Electroforce 3300, TA Electroforce)
equipped with a temperature controlled water chamber set to 35 ± 0.1 °C. An
inner reactor attached to the lower platen of diameter 25 mm was filled with
PBS. The upper, 23 mm diameter platen was controlled first manually to detect
contact with the specimen and then by program with the test sequence. During
each test, displacement and force were sampled at 100 Hz, to precisions of 1 µm
and 0.3 N, respectively.From detected contact, the test sequence compressed the specimen by a nominal 15%
in 0.5 seconds and held 30 seconds, before increasing compression to 30% over 30
seconds. The latter compression was repeated after rapid decompression to 15%
followed by a 30-second hold. The elastic modulus was calculated for compression
between 15% and 30%.
Transmission Electron Microscopy
The tissue was fixed in a mixture of 2% glutaraldehyde and 0.5% paraformaldehyde
in cacodylate buffer for 24 hours at 4 °C. Afterwards the tissue was post-fixed
in 2% osmium tetroxide for 2 hours at 4 °C and further dehydrated, infiltrated,
and embedded in epoxy resin (Epon). After polymerization, semi-thin sections
were cut and stained with toluidine blue in order to localize the region of
interest for making ultrathin sections. The epoxy blocks were then trimmed with
respect to the structure of interest, and 70-nm ultrathin sections were cut on
an ultramicrotome (Leica, UPC6) followed by staining with 4% uranyl acetate in
40% ethanol and Reynolds’ lead citrate. Finally, the ultrathin sections were
examined in a transmission electron microscope (Tecnai12, FEI).
Second Harmonic Generation Microscopy
Samples were fixed in 4% formalin and embedded in paraffin before being cut (4
µm) and mounted on glass slides. The sections were deparaffinized and rehydrated
using standard laboratory procedures and finally mounted with ProLong Gold
antifade, containing DAPI. Second harmonic generation (SHG) microscopy was
performed on a Leica SP8 confocal imaging system equipped with a Coherent Vision
S femtosecond laser tuned to 890 nm for SHG from collagen and for 2-photon
excitation of DAPI. SHG was detected using a non-descanned transmitted light
detector (conventional PMT) with a 435- to 455-nm bandpass filter. DAPI was
collected with a non-descanned reflected light detector (Hybrid PMT) with a 500-
to 550-nm bandpass filter. Images were collected with a 25× objective with
numerical aperture of 0.9. A 2D Gaussian filter with a 0.5 standard deviation of
0.5 and a 2D median filter with a 3 × 3 kernel was used to reduce noise in both
channels. A gamma of 0.5 was applied to the SHG channel to enhance the
visibility of the lower intensities.
Results
Addition of BMP2 but Not IGF1 Improved Cartilage Disc Formation in 3-Week
Confined 3D Cultures
In our first series of experiments we wanted to test the impact of the known
anabolic factors BMP2 and IGF1 on cartilage disc formation in 3-week transwell
cultures. Chondrocytes were cultured in the presence of bFGF in medium
containing either hPLP or autologous serum. Cells were then redifferentiated in
CDM alone, CDM supplemented with either BMP2 or IGF1 or in CDM with both factors
(
). Cartilage samples were analyzed by visual inspection and real-time
RT-qPCR on day 21. Cells expanded in hPLP and then redifferentiated on transwell
membranes in the absence of BMP2 aggregated to form pellets, regardless of the
absence or presence of IGF1 in the differentiation medium (
). An additional experiment exposing chondrocytes to either CDM alone or
CDM supplemented with BMP2 was performed. BMP2-induced changes in cell
morphology or apparent differences in the actin cytoskeleton
could not be revealed by phalloidin staining (Suppl. Fig. S1). Cells expanded in medium supplemented with
autologous serum and then redifferentiated in the absence of BMP2 usually
attached to the membrane, but the discs were thin and frail. Cells
redifferentiated in transwell inserts in the presence of BMP2 always made robust
cartilage discs.
Figure 1.
(a) OA chondrocytes from donor 1 (D1) and donor 2 (D2) were
expanded in bFGF-supplemented medium containing either hPLP or
autologous serum (AS) and redifferentiated for 3 weeks in transwell
inserts (confined) in the presence or absence of BMP2 and/or IGF1.
(b) Examples showing cartilage constructs from cells
expanded in hPLP (images with same scale). Chondrocytes formed solid
discs in the presence but not in the absence of BMP2, independent of
supplementation with IGF1. (c) Real-time RT-qPCR.
Expression of COL2A1, ACAN,
COL1A1, and COL10A1 mRNA. No data
for D2 expanded in serum are available.
(a) OA chondrocytes from donor 1 (D1) and donor 2 (D2) were
expanded in bFGF-supplemented medium containing either hPLP or
autologous serum (AS) and redifferentiated for 3 weeks in transwell
inserts (confined) in the presence or absence of BMP2 and/or IGF1.
(b) Examples showing cartilage constructs from cells
expanded in hPLP (images with same scale). Chondrocytes formed solid
discs in the presence but not in the absence of BMP2, independent of
supplementation with IGF1. (c) Real-time RT-qPCR.
Expression of COL2A1, ACAN,
COL1A1, and COL10A1 mRNA. No data
for D2 expanded in serum are available.Failure to form discs is the reason why real-time RT-qPCR data from hPLP-expanded
cells redifferentiated without BMP2 are absent from
. There were minor differences in the levels of mRNA expression of
COL1A1, COL2A1, ACAN, and
COL10A1 between the different conditions. However, absence
of BMP2 reduced the expression of COL10A1 mRNA in discs made by
cells expanded in medium supplemented with autologous serum, and IGF1 tended to
increase the expression of COL10A1 (
).Based on these observations, CDM supplemented with BMP2 was used in all future
experiments and called CDMB.
Improved Disc Thickness under Unconfined Differentiation Conditions
Seeding 0.5 × 106 actively proliferating cells in an insert placed
within a small well limits the volume of medium and thus of nutrients available
for the chondrocytes. To possibly improve on this, we established cultures where
the discs were stripped off the membranes on day 10 of chondrogenic
redifferentiation and allowed to float freely in slowly shaken 6-well plates —
unconfined condition (
). This approach was adapted and modified from Anderson et
al.
Unconfined conditions produced discs with approximately double thickness
compared with confined conditions on day 21 (
). The expression of cartilage relevant genes did not consistently
parallel the difference in disc thickness (
).
Figure 2.
(a) OA chondrocytes from D1 and D2 were expanded in
bFGF-supplemented medium containing either hPLP or AS and
redifferentiated for 3 weeks under confined or unconfined conditions.
(b) Real-time RT-qPCR. Expression of
COL2A1, ACAN,
COL1A1, and COL10A1 mRNA.
Immunofluorescence of (c) COL2 (red) and (d)
COL10 (white) expression in confined and unconfined cartilage discs
after 3 weeks of redifferentiation. Examples from chondrocytes expanded
in either hPLP- or AS-supplemented medium. Nuclear staining with DAPI is
presented in blue color. Sections of confined cartilage discs include
the membrane. Scale bar = 200 µm.
Table 1.
Thickness of Cartilage Discs.
Expansion Condition
Mode of Chondrogenic Redifferentiation
Thickness (nm)
Donor 1
hPLP
Confined
306
hPLP
Unconfined
640
Serum
Confined
381
Serum
Unconfined
720
Donor 2
hPLP
Confined
340
hPLP
Unconfined
760
Serum
Confined
412
Serum
Unconfined
760
hPLP = human platelet lysate plasma.
(a) OA chondrocytes from D1 and D2 were expanded in
bFGF-supplemented medium containing either hPLP or AS and
redifferentiated for 3 weeks under confined or unconfined conditions.
(b) Real-time RT-qPCR. Expression of
COL2A1, ACAN,
COL1A1, and COL10A1 mRNA.
Immunofluorescence of (c) COL2 (red) and (d)
COL10 (white) expression in confined and unconfined cartilage discs
after 3 weeks of redifferentiation. Examples from chondrocytes expanded
in either hPLP- or AS-supplemented medium. Nuclear staining with DAPI is
presented in blue color. Sections of confined cartilage discs include
the membrane. Scale bar = 200 µm.Thickness of Cartilage Discs.hPLP = human platelet lysate plasma.Staining of frozen sections for COL1, COL2, ACAN, and COL10 gave semiquantitative
results for the presence of ECM molecules. As shown in
, unconfined cartilage discs tended to give stronger COL2 staining
compared with confined discs. In contrast to confined discs, where COL10
positive cells could not be seen, unconfined discs revealed intracellular COL10
expression in a few cells (
).At the end of these experiments the expansion medium was chosen to be hPLP
supplemented with bFGF. Autologous serum with bFGF gave similarly good results,
but required inconveniently large amounts of blood from the donor in order to
obtain large numbers of chondrocytes. Based on disc thickness in combination
with trends in real-time RT-qPCR and staining analyses, unconfined
differentiation culture conditions were chosen over confined conditions. For the
following experiments inserts were transferred from 24-well plates to 6-well
plates on day one of differentiation culture using custom-made adaptors.
Differentiation of Chondrocytes in the Presence of GDF5, FGF18, or Short-Term
Exposure to TGFβ1 Did Not Increase Cartilage Disc Quality in 6-Week Unconfined
Cultures
To further enhance the CDMB cocktail, we next tested the influence of other
growth factors in the disc differentiation model in a new set of donor cells in
the following parallel experiments: (1) CDMB (control), (2) CDMB supplemented
with 100 ng/mL GDF5,
(3) CDMB where TGFβ1 was withdrawn after 72 hours, and (4) CDMB
supplemented with 100 ng/mL FGF18
between days 7 and 14 (
). The results of real-time RT-qPCR analyses are shown in
. Compared with CDMB alone, addition of GDF5 or FGF18 gave similar or
lower levels of COL2A1 and ACAN both at 3 and
6 weeks. The levels of COL1A1 were consistently higher when
FGF18 was added to the differentiation mixture, while the results when GDF5 was
added were similar or slightly lower compared with CDMB alone.
COL10A1 mRNA was expressed at very low levels at 3 weeks in
all conditions of differentiation. However, at 6 weeks CDMB gave the highest
COL10A1 levels. Transient supplementation with TGFβ1 for
only 3 days gave similar or slightly higher levels of COL2A1
and ACAN compared with supplementation throughout the
differentiation culture in CDMB, and considerably lower levels of
COL1A1 and COL10A1 mRNA.
Figure 3.
(a) OA chondrocytes from D3 and D4 were expanded in
bFGF-supplemented medium containing hPLP and redifferentiated for 3 and
6 weeks under unconfined conditions in differentiation medium CDMB
(control) or CDMB supplemented with FGF18 or GDF5, or with
TGFβ1-withdrawal after 3 days of exposure. (b) Real-time
RT-qPCR. Expression of COL2A1, ACAN, COL1A1, and
COL10A1 mRNA shown for 2 donors (white and grey
bars). (c) Immunofluorescence staining of cartilage discs
after 6 weeks of redifferentiation. COL2 expression in samples exposed
to TGFβ1 for only 3 days (−TGFβ1). Example from 2 different donors.
Scale bar = 500 µm. (c) Discs redifferentiated in CDMB,
CDMB + FGF18, and CDMB + GDF5 stained for COL2 (red), ACAN (red), COL1
(green; scale bar = 1000 µm), and COL10 (white; scale bar = 200 µm)
expression. Nuclear staining with DAPI is presented in blue color.
(a) OA chondrocytes from D3 and D4 were expanded in
bFGF-supplemented medium containing hPLP and redifferentiated for 3 and
6 weeks under unconfined conditions in differentiation medium CDMB
(control) or CDMB supplemented with FGF18 or GDF5, or with
TGFβ1-withdrawal after 3 days of exposure. (b) Real-time
RT-qPCR. Expression of COL2A1, ACAN, COL1A1, and
COL10A1 mRNA shown for 2 donors (white and grey
bars). (c) Immunofluorescence staining of cartilage discs
after 6 weeks of redifferentiation. COL2 expression in samples exposed
to TGFβ1 for only 3 days (−TGFβ1). Example from 2 different donors.
Scale bar = 500 µm. (c) Discs redifferentiated in CDMB,
CDMB + FGF18, and CDMB + GDF5 stained for COL2 (red), ACAN (red), COL1
(green; scale bar = 1000 µm), and COL10 (white; scale bar = 200 µm)
expression. Nuclear staining with DAPI is presented in blue color.Measurement of disc thickness showed that CDMB with or without FGF18
supplementation yielded similar results, CDMB with GDF5 supplementation gave
thinner discs, and CDMB with only transient TGFβ1 supplementation even thinner
discs (
). Measurement of disc wet weight gave similar results, with transient
TGFβ1 supplementation giving the lowest weights (
).
Table 2.
Wet Weight and Thickness of Cartilage Discs in Unconfined Culture.
Medium Condition
Donor 3
Donor 4
Weight (mg)
Thickness (mm)
Weight (mg)
Thickness (mm)
3 weeks
6 weeks
6 weeks
3 weeks
6 weeks
6 weeks
CDMB
42.7
95.1
1.79
50.7
103.1
1.82
−TGFβ1
38.8
67.7
1.07
30.5
60.3
1.32
FGF18
50.4
114.3
1.93
46.6
90.3
1.79
GDF5
41.3
92.9
1.46
45.5
102.8
1.67
Wet Weight and Thickness of Cartilage Discs in Unconfined Culture.Immunofluorescence analysis further confirmed that transient TGFβ1
supplementation was inferior to persistent TGFβ1 in the CDMB: the discs were
thin with fragile tissue at the edges for both donors (
). Immunostaining of discs made under the other 3 conditions gave similar
staining for COL2, COL1, and ACAN (
). Again, COL10 was present only as intracellular protein, expressed in
some cells in the periphery of the disc (
). As supplementation of CDMB with additional growth factors did not
result in significant improvements, future experiments were carried out with
CDMB only.
Imaging Analyses and Mechanical Testing
Using CDMB and redifferentiated chondrocytes from another 4 donors we went on to
examine the cartilage discs for mechanical properties and appearance using other
imaging modalities (
). Histology, disc weight, and gene expression did not show significant
differences between samples and was similar to the 6-week cartilage discs grown
in CDMB of the previous experiment (donors 3 and 4). At 6 weeks the ratio of
COL2A1/COL1A1 mRNA was median 26.7 (range
17.0-55.1) for donors 5 to 8 while the ratio for
COL2A1/COL10A1 was median of 20.0 (range
6.5-24.0).
Figure 4.
(a) Chondrocytes from D5, D6, D7, and D8 were expanded in
bFGF-supplemented medium containing hPLP and redifferentiated for 6
weeks under unconfined conditions in differentiation medium CDMB.
Samples were analyzed by real-time RT-qPCR, immunofluorescence, TEM, SHG
microscopy, and mechanical testing. (b) Young’s modulus of
cartilage discs from 3 donors. Measurements were performed unconfined at
35 °C in PBS.
(a) Chondrocytes from D5, D6, D7, and D8 were expanded in
bFGF-supplemented medium containing hPLP and redifferentiated for 6
weeks under unconfined conditions in differentiation medium CDMB.
Samples were analyzed by real-time RT-qPCR, immunofluorescence, TEM, SHG
microscopy, and mechanical testing. (b) Young’s modulus of
cartilage discs from 3 donors. Measurements were performed unconfined at
35 °C in PBS.Young’s modulus was similar for the 3 tested samples with values between 140 kPa
and 234 kPa (
). The concavity of the disc surface from donor 8 prevented the
calculation of Young’s modulus of this disc.A comparison of cartilage discs using transmission electron microscopy (TEM)
showed the formation of collagen fibrils throughout the sections of cartilage
samples and supported the similarity between discs (
, Suppl. Fig. S2). In general, more dead cells were observed in the
central region. The fibrils showed a thickness of approximately 25 nm.
Figure 5.
Transmission electron microscopy. Example shown from one donor (donor 5).
The presented selection is a frontal sample from the middle of the
cartilage disc (left). Cross section of the cartilage disc (center)
showing sites of TEM images of the matrix (right, scale bar = 500
nm).
Transmission electron microscopy. Example shown from one donor (donor 5).
The presented selection is a frontal sample from the middle of the
cartilage disc (left). Cross section of the cartilage disc (center)
showing sites of TEM images of the matrix (right, scale bar = 500
nm).SHG microscopy was also used for detection of fibrillar collagen. Representative
pictures of the SHG signal from cartilage disc sections showed some variation in
structure and density across thickness (
, Suppl. Fig. S3). In general, the pattern revealed a layer with less
dense collagen in the center of the disc accompanied by layers with denser
collagen on either side. SHG suggested that many fibrils were oriented
perpendicular to the disc surface.
Figure 6.
Second harmonic generation microscopy. Examples from cartilage discs
based on chondrocytes from 2 donors (donors 6 and 7). The section (left)
is a frontal sample from the middle of the cartilage disc at low
magnification (scale bar = 200 µm) showing sites of selected
high-resolution images (right, scale bar = 50 µm). Fibrillar collagen
presents in red, nuclear staining with DAPI presents in green.
Second harmonic generation microscopy. Examples from cartilage discs
based on chondrocytes from 2 donors (donors 6 and 7). The section (left)
is a frontal sample from the middle of the cartilage disc at low
magnification (scale bar = 200 µm) showing sites of selected
high-resolution images (right, scale bar = 50 µm). Fibrillar collagen
presents in red, nuclear staining with DAPI presents in green.Taken together, our results show cartilage discs with a strong presence of COL2,
with a disc height approximately that of articular cartilage in adult ankles and
with mechanical properties approaching but not similar to human articular
cartilage.
Discussion
Despite new materials and approaches in tissue engineering, replacement of native
articular cartilage with its unique functional properties remains a major challenge
in cartilage repair. Using autologous chondrocytes and a scaffold-free approach,
biocompatibility problems and potential limitations introduced by a synthetic
scaffold are avoided. The aim of this study was to establish and to optimize a
reliable model of scaffold-free cartilage disc production for potential application
in the clinic using human articular chondrocytes. Simple modifications to the basic
model, such as using unconfined culture conditions and adding BMP2 to the
differentiation medium, allowed for the engineering of almost 2-mm-thick cartilage
discs in 6 weeks of 3-dimensional culture. The discs contained abundant COL2,
collagen fibrils 25 nm in width with a gross orientation perpendicular to the disc
surface, and were shown to have a Young’s modulus of approximately 200 kPa. Although
more research is required to make perfect hyaline cartilage in the laboratory, we
believe these improvements bring engineered cartilage discs closer to the quality
required for therapeutic transplantations.In our first set of experiments we expanded chondrocytes in medium containing either
hPLP or autologous serum. According to GMP guidelines, animal products should be
replaced by human alternatives for clinical translation.
Both hPLP and autologous serum turned out to be good options for chondrocyte
expansion. However, for research-based experiments hPLP is the more convenient
alternative as it can be used as an off-the-shelf product. The large number of
donors included in the plasma and platelet lysate pools also reduces the impact of
patient-to-patient variability.We tested supplementation of CDM with BMP2 and IGF1. The anabolic growth factor IGF1
is involved in cartilage homeostasis
and BMP2 is relevant for cartilage development and matrix
production.[18-21] IGF1 did not improve outcome
in our cartilage disc assay, and tended to increase the levels of cartilage
hypertrophy marker COL10A1 mRNA. A similar increase has been
observed in another chondrocyte culture model.
The addition of BMP2 to CDM, referred to as CDMB, turned out to be of major
importance for reliable disc formation in our model: while discs cultured without
BMP2 either collapsed into small pellets or gave thin and fragile discs, the
addition of BMP2 robustly gave discs with a thickness approaching that seen in adult
weight-bearing joints. BMP2 is not routinely used in chondrogenic differentiation
media, and omission of BMP2 might be the reason for the disc collapse reported by
groups using uncoated inserts.[23,24] Since no discs could be
formed in the absence of BMP2, its effect on the actin cytoskeleton was tested in
chondrocytes grown in monolayer. Phalloidin staining did not show clear differences.
However, an impact of BMP2 might possibly be observed in 3D. Interestingly, adding
BMP2 to CDM did not impact importantly on the mRNA expression of chondrogenic genes
COL2A1 and ACAN, but greatly increased the
production of cartilage ECM. Similar observations have been made using human
mesenchymal stromal cells (hMSCs).[20,24] The mechanism regulating this
effect has not been fully investigated, although a study using mouse chondrocytes
suggests that BMP2 may impact on the type of procollagen produced.
Although the use of BMP2 has been related to hypertrophy of chondrocytes and
calcification of cartilage ECM associated with increased expression of COL10 mRNA
and protein,[26-28] Payr et al.
have argued that hypertrophy and expression of osteogenic markers after BMP2
stimulation might be more relevant when using MSCs than human articular chondrocytes.
Still, the role played by BMP2 in the CDMB deserves further
investigation.With respect to IGF1, a study on the redifferentiation capacity of human chondrocytes
in pellet cultures has shown that TGFβ1 alone had positive effects on expression of
ECM components under normoxia, whereas a positive effect of IGF1 in combination with
TGFβ1 was only seen under hypoxic conditions.
In this context, beneficial effects of IGF1 in our experiments might not be
detectable under normoxic conditions. Another possibility could be impaired
responsiveness to IGF1, which has been reported for aged
and for osteoarthritic chondrocytes.Furthermore, we compared 2 different approaches of cartilage disc formation —
confined and unconfined culture conditions. The latter approach resulted in
increased thickness of the discs. Liberation of the freshly formed discs from
transwell inserts presumably gives a better supply of nutrients from all sides of
the disc and a more stable environment due to a greater volume of the culture
medium. Additionally, the slight movement of unconfined discs might contribute to
matrix production, which is in accordance with the observation that mechanical
stimulation is beneficial for cartilage formation and cartilage tissue
engineering.[33-35]In addition to BMP2 and IGF1, we also tested other redifferentiation cocktail
ingredients that might improve cartilage disc formation. FGF18
and GDF5
have been reported to contribute to matrix production and chondrogenesis, but
did not show beneficial effects in our experiments. Murphy et al.
suggested that supplementation of their CDM with GDF5 in addition to TGFβ1 and BMP2
reduced COL1 synthesis in articular chondrocytes.
Numerical values for COL1A1 mRNA levels were lower also in
our experiments when GDF5 was added, but we consider the differences to be too small
to be relevant. Speaking against addition of GDF5 was also a slightly lower disc
thickness. As FGF18 gave higher COL1A1 mRNA values in the one
experiment, we have so far concluded that FGF18 supplementation does not give a
clear beneficial effect. However, it is possible that intermittent exposure during
redifferentiation might yield more obvious positive effects, perhaps also reducing
COL1A1 levels.
Finally, based on a study which showed that TGFβ1 withdrawal from
chondrogenic differentiation cultures is related to greater cell proliferation
and/or survival and that sustained exposure was not essential for proteoglycan synthesis,
we also wanted to check whether short-term exposure to TGFβ1 in CDMB might be
sufficient to drive chondrogenesis. Interestingly, mRNA levels of
COL2A1 and ACAN were as good or better than
for sustained exposure to TGFβ1, while mRNA values for unwanted molecules
COL1A1 and COL10A1 were lower. However, the
discs themselves were thin and fragile, making this approach unacceptable for our
project. Formation of fragile tissue in the absence of TGFβ has also been observed
by others.Having chosen the expansion medium and differentiation conditions, we finally
evaluated the cartilage discussing TEM and SHG imaging and mechanical testing for
stiffness. TEM and SHG microscopy both confirmed the formation of collagen fibrils.
By TEM, the thickness of the fibrils was measured to be 25 nm. This is similar to
the small prototypic collagen fibrils found in human articular cartilage, and
measured to be 18 ± 5 nm thick.
By SHG microscopy, the orientation of the fibrils were found to be grossly
perpendicular to the disc surface, which is similar to the orientation of collagen
fibrils in the deep zone of articular cartilage.
The values obtained for Young’s modulus were lower than those obtained for
native articular cartilage,[40-42] but
comparable to those published previously for discs made from hMSC.
We speculate that it may be difficult to obtain much higher values for tissue
stiffness in the absence of periodic loading similar to that exerted on articular
cartilage during walking.Since we wanted to test many parameters (different expansion media, confined vs.
unconfined differentiation conditions, several differentiation factors) using
different assays, we have tested only 2 donors for the first series of experiments.
As this precludes the use of statistics, we only describe very robust observations
as important such as the use of unconfined differentiation cultures and the
importance of BMP2 for matrix production. Had we wanted to identify less important
differences, using biological replicates, we would have had to include a very large
number of donors. At this stage we believe such differences would not impact greatly
on the end product: transplantable autologous cartilage discs. For the second set of
experiments, chondrocytes from 4 donors were used, of which 2 donors had been
operated for insertion of prosthesis due to OA, while the other 2 donors were
operated for non-OA conditions. Acknowledging that the sample size and number of
assays are small, we found that disc thickness was at least as large in discs made
from OA chondrocytes, and we saw no discernable differences in any of the other
assays presented here between discs made from OA and non-OA chondrocytes.
Conclusion
Here we present an improved scaffold-free method of reliable cartilage formation
using articular chondrocytes that results in discs with a thickness and stiffness
approaching those of the articular cartilage of knees and ankles.[44,45] Our research
shows that BMP2 is essential for robust disc formation and that unconfined
conditions for the differentiation culture greatly improved matrix production. The
discs contained abundant type II collagen and fibrils that tended to be oriented
perpendicular to the disc surface. These results suggest that therapeutic trials
using scaffold-free cartilage disc implants may be possible in the not too distant
future.Click here for additional data file.Supplemental material, sj-pdf-1-car-10.1177_19476035211007923 for Scaffold-Free
Engineering of Human Cartilage Implants by Nadine Frerker, Tommy A. Karlsen,
Magnus Borstad Lilledahl, Sverre-Henning Brorson, John E. Tibballs and Jan E.
Brinchmann in CARTILAGE
Authors: Vanessa J Bianchi; Joanna F Weber; Stephen D Waldman; David Backstein; Rita A Kandel Journal: Tissue Eng Part A Date: 2016-12-19 Impact factor: 3.845
Authors: A Gigout; H Guehring; D Froemel; A Meurer; C Ladel; D Reker; A C Bay-Jensen; M A Karsdal; S Lindemann Journal: Osteoarthritis Cartilage Date: 2017-08-18 Impact factor: 6.576
Authors: Alan D Murdoch; Lisa M Grady; Matthew P Ablett; Theoni Katopodi; Roger S Meadows; Tim E Hardingham Journal: Stem Cells Date: 2007-07-26 Impact factor: 6.277